May 14, 2019
Duesseldorf, May 14, 2019 – Dr. Bernd Metzner (48) takes up the position of Chief Financial Officer of Gerresheimer AG on May 15, 2019. Dr. Metzner had been Chief Financial Officer of SDAX-listed Ströer SE & Co. KGaA since 2014.
“I very much welcome the financial expertise and years of industry experience that Dr. Bernd Metzner brings to the Management Board. Together with him and Dr. Lukas Burkhardt, we make a strong Management Board team that will drive Gerresheimer’s sustainable growth forward,” says Dietmar Siemssen, CEO of Gerresheimer AG.
After studying business administration in Siegen, Germany, completing his doctorate and starting his career at a law firm, Dr. Metzner held various management positions in finance at the Bayer Group between 2002 and 2011. Among other roles, he was responsible for coordinating the carve-out and initial public offering of Lanxess, and held the position of CFO at Bayer Italy as well as that of global CFO in Bayer’s Pharmaceuticals Division. Before joining Ströer, he served as CFO of the global, family-owned Döhler Group from mid-2011 to mid-2014.
The Management Board of Gerresheimer AG (as of May 15, 2019):
- Dietmar Siemssen, CEO
responsible among other things for the Plastics & Devices and Advanced Technologies Divisions - Dr. Bernd Metzner, CFO
- Dr. Lukas Burkhardt, Management Board member
responsible for the Primary Packaging Glass Division
About Gerresheimer
Gerresheimer is a leading global partner to the pharma and healthcare industries. The company’s special glass and plastic products contribute to health and well-being. Gerresheimer is a global organization with about 10,000 employees and manufacturing operations in the local markets, close to customers. With plants in Europe, North and South America and Asia Gerresheimer generates revenues of approximately EUR 1.4 billion. The comprehensive product portfolio includes pharmaceutical packaging products as well as convenient and safe drug delivery systems such as insulin pens, inhalers, micro pumps, prefillable syringes, vials, ampoules, bottles and containers for liquid and solid pharmaceuticals with closure and safety systems, plus cosmetic packaging products.